Journey Colab is developing synthetic Mescaline HCl as a therapeutic for patients with alcohol use disorder, integrating it with psychotherapy and community support to enhance treatment efficacy. The startup addresses the high relapse rates in addiction care by promoting durable remission through a scientifically validated and equitable care model.
Funding
$18.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current addiction treatment methods often result in high relapse rates, with only a small percentage of patients achieving lasting recovery. The lack of effective and durable solutions contributes to significant personal and economic burdens.
Solution
Journey Colab is developing a novel approach to addiction treatment by combining psychedelic therapeutics with integrated care models. Their lead drug program, JOUR-5700, utilizes synthetic Mescaline HCl in conjunction with psychotherapy and community support to promote durable remission for patients with alcohol use disorder. This integrated model aims to address the underlying causes of addiction and provide a more comprehensive and effective path to recovery. By focusing on both pharmacological and psychosocial interventions, Journey Colab seeks to improve patient outcomes and reduce relapse rates associated with traditional addiction treatments. The company is also establishing a network of Centers of Excellence in collaboration with addiction treatment centers across the U.S. to facilitate real-world research and improve equitable access to care.
Target Audience
The primary target audience includes individuals suffering from alcohol use disorder, addiction treatment centers, and clinical researchers focused on developing innovative approaches to addiction care.
Features
- Development of JOUR-5700, a synthetic Mescaline HCl therapeutic for alcohol use disorder
- Integrated care model combining pharmacotherapy with psychotherapy and community support
- Network of Centers of Excellence for real-world research and equitable access to care
- Focus on achieving durable remission and reducing relapse rates
- Stakeholder structure that dedicates a portion of equity to community stakeholders, including Indigenous communities